IRIS Institutional Research Information System - OPENBS Open Archive UniBS

OMODEI, Umberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.175
EU - Europa 1.076
AS - Asia 511
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 4.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.173
UA - Ucraina 528
CN - Cina 390
DE - Germania 207
FI - Finlandia 106
IN - India 106
IE - Irlanda 72
IT - Italia 68
GB - Regno Unito 57
FR - Francia 18
BE - Belgio 11
TR - Turchia 11
BR - Brasile 7
EU - Europa 5
SE - Svezia 5
AU - Australia 2
CA - Canada 2
KR - Corea 2
BD - Bangladesh 1
BY - Bielorussia 1
JO - Giordania 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 4.776
Salva come PNG Salva come JPEG
Città #
Fairfield 465
Woodbridge 461
Jacksonville 357
Houston 343
Ann Arbor 282
Cambridge 212
Ashburn 211
Seattle 194
Wilmington 185
Princeton 144
Nanjing 109
Dublin 72
Chandler 71
Beijing 56
Dearborn 53
Helsinki 35
Nanchang 31
Milan 25
San Diego 24
Changsha 21
Jiaxing 20
Jinan 20
Kunming 20
Hebei 19
Tianjin 18
Brescia 17
Shenyang 16
Washington 14
London 13
Brussels 11
Hangzhou 11
Boardman 10
Kocaeli 10
Hefei 8
Ningbo 8
Verona 8
Indiana 7
San Francisco 7
Lanzhou 6
Norwalk 6
Guangzhou 5
Des Moines 4
Taiyuan 4
Zhengzhou 4
Haikou 3
New York 3
Nürnberg 3
Orange 3
Ronchi Dei Legionari 3
Fuzhou 2
San Giacomo delle Segnate 2
Taizhou 2
Walnut 2
Yellow Springs 2
Acton 1
Amman 1
Augusta 1
Bardolino 1
Chaoyang 1
Dhaka 1
Falkenstein 1
Frankfurt am Main 1
Greenwich 1
Hanover 1
Horia 1
Hounslow 1
Huntersville 1
Los Angeles 1
Markham 1
Melbourne 1
Minsk 1
New Bedfont 1
New Delhi 1
Redmond 1
Saint Petersburg 1
Sydney 1
Toronto 1
Totale 3.665
Salva come PNG Salva come JPEG
Nome #
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women 127
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. 116
Identification of osteoporosis risk in postmenopausal women by the combined use of ultrasounds and clinical factors 109
Can salin infusion sonohysterography (SIS) replace diagnostic hysteroscopy in the uterine cavity evaluation of infertile women? 104
FSH receptor polymorphisms in a population of infertile women and controls 104
General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy 104
Clinical Impact of a New Italian Law Regulation on Assisted Reproduction Technologies 99
Risk identification of osteoporosis in postmenopausal women by a simple algorithm based on ultrasound densitometry and body mass index 98
Factors associated with total cholesterol levels in women around menopause attending menopause clinics in Italy 96
Risk factors for clinically diagnosed uterine fibroids in women around menopause. 96
Effect of acupuncture on rates of pregnancy among women undergoing in vitro fertilization 93
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. 92
Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 92
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Clinical Data 88
Determinants of body mass index in women around menopause attending menopause clinics in Italy. 88
Chromosome Abnormalities and Yq microdeletions in Infertile italian couples referred for assisted reproductive tecnique 87
Risk of low bone density in women attending menopause clinics in Italy 87
Effect of soy-derived isoflavones on hot flashes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 87
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. 86
Risk factors for high blood pressure in women attending menopause clinics in Italy. 84
The Effect of HRT on Endometrial Thickness (ET) and Uterine Arterial Blood Flow Assessed by Transvaginal Ultrasound (TVU). 84
Ovulation induction with intravenous gonadotropin-releasing hormone 84
Serum progesterone level on the day of oocyte retrieval correlates with the ovarian response but not predict pregnancy rate 83
Endometrial thickness and histological abnormalities in women on hormonal replacement therapy: a transvaginal ultrasound/hysteroscopic study 82
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. 81
Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003. 80
Osteoporosis Risk Profile for Peri-and Postmenopausal Women Attending Menopause Clinics in Italy 80
Sequential Conjugated Estrogens Plus Medrogestone HRT Regimen Versus Tibolone: A Comparative Randomized Study 79
Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study. 78
Frequency of Cardiovascular Risks Factor in Women Attending Menopause Clinics: Findings from the ICARUS Data Base 78
Risk of low bone density in women attending menopause clinics in Italy. 78
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Impact on Lipid Metabolism 77
Determinants of age at menopause in women attending menopause clinics in Italy. 77
Endometrial Changes and Doppler Flow Evaluation in Postmenopausal Breast Cancer Patients on Tamoxifen (TAM): A Transvaginal Ultrasound (TVU)/Hysterescopy Study 77
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. 74
Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. 72
Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy 64
Profiles and endocrine correlations in endometrial carcinoma. 62
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 59
CUMCS: FINDINGS FROM THE ICARUS DATA BASE 58
Endometrial Evaluation in Postmenopausal Bleeding: Transvaginal Sonografy Versus Hysteroscopy 55
Pituitary microprolactinoma, bromocriptine, and pregnancy: follow-up of 74 cases 53
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 52
A new method for free testosterone assay: clinical evaluation. 51
A new method for free testosterone assay: clinical evaluation. 49
Continuous combined HRT in post-menopause: two regimen comparative study 48
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 48
Profiles and endocrine correlations in endometrial carcinoma. 47
Polycystic ovary syndrome: long-term evolution. 46
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 46
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 46
Outlook on Continuous Estrogen-Progestin Therapy. 45
Ovarian hyperstimulation syndrome (OHS): a case of severe OHS. 45
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial 45
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 45
Polycystic ovary syndrome: long-term evolution. 44
The impact of HRT on endometrial thickness—do cut‐off values exist? 43
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 43
Rischio oncologico 43
Effects of Recombinant Follicle-Stimulating Hormone on Bone Turnover Markers in Infertile Women Undergoing in Vitro Fertilization Procedure 41
Premarin 0.625 vs Estraderm TTS 50 Have These Two" Standard Doses" the Same Biological Effects? 41
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 39
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 38
Fibrocystic Disease of the Breast Associated with Pituitary‐Ovarian Dysfunction: Results of Treatment with Bromocriptine 38
EVALUATION OF BLEEDING AND CONTROL OF CLIMACTERIC SYMPTOMS OBSERVED WITH TWO TRANSDERMAL PREPARATIONS CONTAINING ESTRADIOL AND NORETHISTERONE ACETATE 38
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 37
EFFECTS OF SOY-DERIVED ISOFLAVONES ON HOT FLUSHES AND VASCULAR REACTIVITY 36
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 35
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 35
La patologia endometriale e la sorveglianza della paziente in postmenopausa 34
Mammella: è possibile la chemioprevenzione? 34
Identificazione del rischio di osteoporosi in donne in postmenopausa mediante l’uso combinato di ultrasuoni e fattori clinici. 29
Totale 4.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019564 0 0 0 0 45 29 42 72 1 72 160 143
2019/20201.523 226 42 44 193 74 182 158 162 92 191 60 99
2020/2021898 5 134 9 102 22 141 24 143 103 100 96 19
2021/2022450 14 116 2 28 1 39 26 38 35 50 8 93
2022/2023301 74 1 6 27 20 99 0 20 29 4 9 12
2023/2024116 10 4 33 43 26 0 0 0 0 0 0 0
Totale 4.813